TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

SODIUM NITROPRUSSIDE
Cardiovascular Approved 2017-03-08
1
Indication
--
Phase 3 Trials
9
Years on Market

Details

Status
Prescription
First Approved
2017-03-08
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

Companies

Active Ingredient: SODIUM NITROPRUSSIDE

NIPRIDE RTU IN SODIUM CHLORIDE 0.9% Approval History

Loading approval history...

What NIPRIDE RTU IN SODIUM CHLORIDE 0.9% Treats

2 indications

NIPRIDE RTU IN SODIUM CHLORIDE 0.9% is approved for 2 conditions since its original approval in 2017. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypertension
  • Congestive Heart Failure
Source: FDA Label

NIPRIDE RTU IN SODIUM CHLORIDE 0.9% Boxed Warning

BOXED WARNING Sodium nitroprusside injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion. Sodium nitroprusside injection can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION ). In patients not properly monitored, these decreases can lead to irreversible ischemic injuries or death. Sodium nitroprusside should be used only when available equipment and personnel allow blood pressure to be con...

Drugs Similar to NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMILORIDE HYDROCHLORIDE
AMILORIDE HYDROCHLORIDE
2 shared
SIGMAPHARM LABS LLC
Shared indications:
Congestive Heart FailureHypertension
CADUET
AMLODIPINE BESYLATE
2 shared
PHARMACIA
Shared indications:
HypertensionCongestive Heart Failure
HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE
2 shared
JUBILANT CADISTA
Shared indications:
Congestive Heart FailureHypertension
INDAPAMIDE
INDAPAMIDE
2 shared
RISING
Shared indications:
HypertensionCongestive Heart Failure
INZIRQO
HYDROCHLOROTHIAZIDE
2 shared
NOVITIUM PHARMA
Shared indications:
HypertensionCongestive Heart Failure
METOLAZONE
METOLAZONE
2 shared
Novartis
Shared indications:
Congestive Heart FailureHypertension
MIDAMOR
AMILORIDE HYDROCHLORIDE
2 shared
PADAGIS US
Shared indications:
Congestive Heart FailureHypertension
ACEBUTOLOL HYDROCHLORIDE
ACEBUTOLOL HYDROCHLORIDE
1 shared
AMNEAL PHARM
Shared indications:
Hypertension
ACETAZOLAMIDE
ACETAZOLAMIDE
1 shared
MANKIND PHARMA
Shared indications:
Congestive Heart Failure
ALDACTONE
SPIRONOLACTONE
1 shared
Pfizer
Shared indications:
Hypertension
ALISKIREN HEMIFUMARATE
ALISKIREN HEMIFUMARATE
1 shared
PH HEALTH
Shared indications:
Hypertension
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE
1 shared
Viatris
Shared indications:
Hypertension
AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
AMLODIPINE BESYLATE
1 shared
Aurobindo Pharma
Shared indications:
Hypertension
AMLODIPINE BESYLATE AND VALSARTAN
AMLODIPINE BESYLATE
1 shared
ALEMBIC
Shared indications:
Hypertension
AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE
AMLODIPINE BESYLATE
1 shared
STRIDES PHARMA INTL
Shared indications:
Hypertension
ARBLI
LOSARTAN POTASSIUM
1 shared
SCIENTURE
Shared indications:
Hypertension
ATACAND
CANDESARTAN CILEXETIL
1 shared
ANI PHARMS
Shared indications:
Hypertension
ATACAND HCT
CANDESARTAN CILEXETIL
1 shared
ANI PHARMS
Shared indications:
Hypertension
ATENOLOL
ATENOLOL
1 shared
AIPING PHARM INC
Shared indications:
Hypertension
ATENOLOL AND CHLORTHALIDONE
ATENOLOL
1 shared
WATSON LABS
Shared indications:
Hypertension
πŸ”¬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
πŸ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

NIPRIDE RTU IN SODIUM CHLORIDE 0.9% FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

INDICATIONS & USAGE Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. Concomitant longer-acting antihypertensive medication should be administered so that the duration of treatment with sodium nitroprusside can be minimized. Sodium nitroprusside is also indicated for producing controlled hypotension in order to reduce bleeding during surgery. Sodium nitroprusside is also indicated for the treatment of acute congestive heart failure.

⚠️ BOXED WARNING

BOXED WARNING Sodium nitroprusside injection is not suitable for direct injection. The solution must be further diluted in sterile 5% dextrose injection before infusion. Sodium nitroprusside injection can cause precipitous decreases in blood pressure (see DOSAGE AND ADMINISTRATION ). In patients not...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.